Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06600659
A Study to Determine Number of Patients Who Develop High Ammonia Levels After Receiving Recombinant Erwinia Asparaginase
Sponsor: Mayo Clinic
View on ClinicalTrials.gov
Summary
This study evaluates the incidence of symptomatic hyperammonemia (high ammonia levels) in patients being treated with recombinant Erwinia asparaginase.
Official title: A Pilot Study to Establish Incidence and Characteristics of Patients at Risk for Symptomatic Hyperammonemia Secondary to Recombinant Erwinia Asparaginase
Key Details
Gender
All
Age Range
1 Year - Any
Study Type
OBSERVATIONAL
Enrollment
10
Start Date
2023-11-02
Completion Date
2026-12-01
Last Updated
2026-02-06
Healthy Volunteers
No
Interventions
OTHER
Non-Interventional Study
Non-interventional study
Locations (1)
Mayo Clinic in Rochester
Rochester, Minnesota, United States